Greenleaf Medical AB announced that the company was issued patent #8,642,098 from the U.S. Patent and Trademark Office (USPTO) for their innovation in health science. The new patent, “Use of plant cell membrane for the treatment of obesity,” issued to Greenleaf Medical AB relates to the use of at least one cell membrane fraction to help retard fat digestion, suppress appetite, body weight and/or lower blood lipids.